Your browser doesn't support javascript.
loading
Quadruple-drug induction HAART in advanced HIV infection.
Maggiolo, Franco; Ripamonti, Diego; Callegaro, Annapaola; Gregis, Giampietro; Quinzan, Giampaolo; Suter, Fredy.
Afiliação
  • Maggiolo F; Division of Infectious Diseases, Antiviral Therapy Unit, Ospedali Riuniti di Bergamo, Italy. franco31556@hotmail.com
HIV Clin Trials ; 6(1): 1-4, 2005.
Article em En | MEDLINE | ID: mdl-15765306
ABSTRACT
A randomized controlled study exploring an induction-maintenance strategy was performed with a quadruple-drug regimen zidovudine/lamivudine/abacavir/nevirapine. The study was prematurely interrupted due to the high proportion of adverse events. The median time on protocol-defined therapy was 110 days; 13/28 (46%) patients interrupted therapy and 2/6 tested patients selected praecox viral mutants. Despite this, we observed a significant (p maintenance strategies are tempered by an increased risk of adverse experiences.
Assuntos
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Terapia Antirretroviral de Alta Atividade Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2005 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Terapia Antirretroviral de Alta Atividade Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2005 Tipo de documento: Article